Research Article
Small Interfering RNA Targeted to ASPP2 Promotes Progression of Experimental Proliferative Vitreoretinopathy
Table 1
Clinical characteristics for individual proliferative retinal membranes.
| | Patient number | Age (y) | Sex | Diagnosis | Duration |
| | 1 | 56 | M | Idiopathic epiretinal membrane | 3 mo | | 2 | 60 | M | Idiopathic epiretinal membrane | 5 wk | | 3 | 37 | F | Idiopathic epiretinal membrane | 2 mo | | 4 | 32 | F | Idiopathic epiretinal membrane | 1 wk | | 5 | 54 | F | Idiopathic epiretinal membrane | 6 mo | | 6 | 68 | F | Idiopathic epiretinal membrane | 4 mo | | 7 | 44 | M | PVR epiretinal membrane | 1 y | | 8 | 23 | M | PVR epiretinal membrane | 3 wk | | 9 | 30 | M | PVR epiretinal membrane | 2 mo | | 10 | 51 | M | PVR epiretinal membrane | 3 mo | | 11 | 37 | F | PVR epiretinal membrane | 5 mo | | 12 | 28 | F | PVR epiretinal membrane | 1 mo |
|
|
Notes: PVR, proliferative vitreoretinopathy; M, male; F, female; mo, month; wk, week; y, year.
|
